A Phase 1 Study of Y-3 in US Healthy Volunteers.

Clinical trial NCT06770491 · COMPLETED

Trial details

NCT number: NCT06770491
Sponsor: Neurodawn Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety Tolerability Pharmacokinetic Study in Healthy Volunteers

Start date: 2025-02-04
Primary completion: 2025-09-20
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.